Figure 1D demonstrates that DLAT expression was upmodulated in 7 distinct cancer types: cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), stomach adenocarcinoma (STAD), and stomach and esophageal carcinoma (STES). The gene discussed is DLAT; the disease is medical procedure.